* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
Hydrophilic linker design can help address the solubility, aggregation, nonspecific binding, and exposure challenges created by the large bifunctional structure of PROTACs. However, adding polarity alone is not enough. Excessive hydrogen-bonding capacity or exposed polar surface area may reduce membrane permeability and weaken intracellular degradation. BOC Sciences provides integrated hydrophilic PROTAC linker design services that balance aqueous behavior, conformational control, ternary complex geometry, cellular uptake, and degradation performance. Our scientists support linker concept generation, custom synthesis, physicochemical characterization, and iterative functional optimization for pharmaceutical, biotechnology, and academic research teams.
Request a Consultation Explore ServicesA hydrophilic PROTAC linker is the connecting chain within a proteolysis-targeting chimera that bridges the target protein ligand and the E3 ubiquitin ligase ligand while contributing inherent water-loving character to the overall degrader molecule. Unlike conventional alkyl-based linkers that add hydrophobicity with each methylene unit, hydrophilic linkers incorporate polar structural elements — most commonly polyethylene glycol (PEG) chains, heteroatom-rich scaffolds, or ionizable functional groups — that improve aqueous solubility, reduce nonspecific protein binding, and help bring the physicochemical profile of PROTAC molecules into a more drug-like space.
How hydrophilic a linker is can be measured by its LogP — a number that describes how a molecule distributes between oil (octanol) and water. A negative LogP means the molecule prefers water; a positive LogP means it prefers oil. Here is the practical difference: each –CH2– unit in an alkyl linker pushes LogP up by roughly +0.5, making the PROTAC more oil-loving and less soluble. Each –OCH2CH2– unit in a PEG linker pulls LogP down by roughly −0.2, making the PROTAC more water-loving. A linker with a negative LogP contribution (< 0) is strongly hydrophilic; one with a contribution between 0 and 3 is moderately lipophilic; and one above 3 is strongly lipophilic, which often leads to poor solubility and excessive sticking to plasma proteins.
We design hydrophilic linkers based on target protein structure, ligand exit vectors, E3 ligase geometry, and project-specific physicochemical targets. Our design process considers linker length, ethylene glycol unit count, polarity distribution, branching, and terminal functionalization — always guided by the goal of achieving productive ternary complex geometry while improving overall molecular solubility. We routinely design PEG linkers (PEG2 through PEG24), mixed PEG-alkyl hybrids, ionizable linker motifs incorporating carboxylic acid or amine groups, and environment-responsive architectures tailored to each target system. For programs requiring integrated degrader construction, clients can combine linker work with our PROTAC design services.
BOC Sciences synthesizes custom hydrophilic linkers and linker-containing intermediates at scales from milligrams to multi-grams. Our synthesis capabilities cover heterobifunctional PEG linkers with orthogonal protecting groups, click-chemistry-ready handles (azide, alkyne, DBCO, BCN), amine- and carboxyl-terminated chains, branched PEG architectures, and hybrid constructs incorporating piperazine, morpholine, sulfonamide, and carbohydrate-derived motifs. Each linker is delivered with full analytical characterization including LC-MS, HRMS, NMR, and HPLC purity assessment. Clients can also access our PROTAC linker catalog for readily available building blocks.
When an existing PROTAC series suffers from poor solubility, weak cellular degradation, or unfavorable permeability, our team performs systematic hydrophilic linker optimization. We explore length gradients, polarity gradients, PEG unit variations, ionizable group introduction, and hybrid architectures to identify the optimal balance between hydrophilicity, conformational control, and degradation potency. Each modification is evaluated in context — not as an isolated linker change but as part of the full degrader structure-activity relationship. For programs requiring binding-site-level refinement, our linker binding site selection service helps identify the most productive attachment vectors.
Linker candidates are validated through an integrated suite of biochemical, biophysical, and cellular assays. We measure ternary complex formation and cooperativity, cellular degradation potency (DC50 and Dmax), target selectivity, aqueous solubility, LogD7.4, and permeability. This multi-parameter characterization ensures that hydrophilic linker modifications deliver real improvements in degrader behavior — not just computational predictions. Our PROTAC ternary complex assay and PROTAC in vitro evaluation platforms provide the experimental data needed to drive confident linker selection.
Need a Hydrophilic Linker Strategy for Your PROTAC Program?
From design and synthesis to functional validation, BOC Sciences delivers integrated hydrophilic linker solutions that improve degrader solubility and cellular performance.
The most widely used class of hydrophilic PROTAC linkers. Linear PEG chains (–OCH2CH2–)n with n = 1–24 provide tunable length, excellent aqueous solubility, and well-characterized conformational behavior. Our PEG linker design services support systematic exploration across PEG length and terminal group combinations.
Beyond pure PEG, we design alkyl linkers incorporating oxygen, nitrogen, and sulfur atoms at strategic positions to increase polarity without full PEG character. These offer intermediate polarity — more hydrophilic than pure alkyl chains but less flexible than PEG — useful for fine-tuning solubility while maintaining some conformational restraint.
Nitrogen- and oxygen-containing heterocycles introduce both polarity and conformational restriction into the linker architecture. These are often embedded within longer constructs to combine the solubility benefits of PEG with the conformational control of a cyclic scaffold — an approach proven effective for linker design and optimization in programs where excessive flexibility limits degradation potency.
Polar functional groups embedded within the linker backbone contribute both hydrophilicity and hydrogen-bonding capacity. These groups are strategically placed to improve solubility, create intramolecular hydrogen bonds that enhance permeability, or provide metabolic anchoring points.
Branching introduces additional hydrophilic groups without proportionally extending linker length. These architectures increase local polarity density, create additional hydrogen-bonding surfaces, and can accommodate orthogonal functional handles within a single linker construct.
These linkers combine hydrophilic segments (PEG, heteroatom-rich chains, or polar heterocycles) with semi-rigid elements (alkyne, trans-alkene, cyclopropane, or aromatic rings) to achieve controlled conformational space while maintaining solubility. They are particularly useful when ternary complex modeling suggests an intermediate degree of conformational freedom is optimal.
Looking for a Specific Hydrophilic Linker Architecture?
Tell us your preferred linker type, target structure, attachment sites, or current design challenges. Whether you need a PEG-based linker, a polar heterocyclic structure, an ionizable segment, or a customized hybrid architecture, BOC Sciences can help evaluate the design space and develop a practical solution for your PROTAC project.
Beyond individual linker chemistries, BOC Sciences applies four distinct design strategies to achieve the right hydrophilic profile for each degrader program. These strategies differ in how hydrophilicity is introduced, controlled, and tuned in response to biological context.
These linkers possess inherent polarity that is independent of pH, temperature, or environmental conditions. The hydrophilic character is built into the covalent structure — it does not switch on or off. Representative structures include PEG chains, polyhydroxy backbones (glycerol or sugar-derived), sulfonate-containing chains with permanent negative charge, and phosphate-containing linkers. The LogP contribution is consistently negative or near zero. Their key advantage is predictability — solubility behavior is stable across all physiological compartments. The limitation is that they cannot adapt to pH gradients; what you design is what you get in every tissue.
These linkers contain ionizable groups whose hydrophilicity changes reversibly with pH, enabling environment-dependent solubility modulation. Carboxylic acid groups (–COOH, pKa ~4–5) are protonated and relatively hydrophobic in acidic environments but become negatively charged and strongly hydrophilic at neutral pH. Amine groups (–NH2, pKa ~9–10) behave oppositely: protonated and hydrophilic in acidic conditions, neutral and more hydrophobic at physiological pH. Sulfonamide groups (–SO2NH–, pKa ~9–11) offer intermediate tunability. The design significance lies in exploiting natural pH gradients: in blood (pH 7.4), carboxylate linkers remain ionized for solubility; in the tumor microenvironment (pH 6.5–6.8), partial protonation increases hydrophobicity and may enhance membrane penetration; in lysosomes (pH 4.5–5.5), amine-containing linkers become highly protonated. Our alkyl linker design services can incorporate these ionizable motifs into hybrid constructs.
These linkers integrate both hydrophilic and hydrophobic segments within a single architecture, enabling fine-tuned control over overall polarity. Four common design modes are employed: (1) hydrophilic-hydrophobic block linkers such as PEG3–(CH2)6–; (2) polar-nonpolar alternating linkers such as –O(CH2)3O(CH2)3– that control conformational entropy; (3) rigid-flexible combinations such as PEG2-piperazine-PEG2; and (4) amphiphilic terminal designs where a PEG chain carries a hydrophobic end-cap. The LogP contribution of these linkers can be designed in the 0–2 range through precise adjustment of the hydrophilic-to-hydrophobic segment ratio, making them ideal for programs where both solubility and membrane permeability must be simultaneously optimized.
The most sophisticated strategy: linkers whose hydrophilicity undergoes irreversible or quasi-irreversible change in response to specific physiological stimuli, enabling spatiotemporally controlled degradation activity. Five response mechanisms are available: (1) enzyme-responsive — PEG chains with protease-cleavable sequences (e.g., Gly-Leu-Phe-Gly for cathepsin B) that shed the PEG segment upon tumor-specific protease cleavage; (2) redox-responsive — disulfide (–S–S–) containing PEG linkers stable in the oxidizing bloodstream but cleaved by high intracellular glutathione (GSH, ~10 mM in tumor cells); (3) ROS-responsive — thioether (–S–) or boronate ester-containing PEG chains that oxidize in inflammatory or tumor environments; (4) temperature-responsive — PNIPAM-like thermosensitive polymer segments that switch hydrophilicity near 42 °C; and (5) photo-responsive — ortho-nitrobenzyl or coumarin-based photocleavable PEG linkers for light-triggered degrader release. These strategies are integrated with our cleavable linker design services for programs requiring conditional activation.
Build a Hydrophilic Linker Strategy Around Your Project Goals
Share your structural requirements, intended function, property goals, current development challenges, or relevant reference literature with our scientists. We can assess the available design space and develop a suitable linker or focused linker series for your PROTAC project.
Project Consultation and Existing Data Review
We review the client's target protein, POI ligand structure, E3 ligase recruiter, existing degrader data, and key performance issues — particularly solubility measurements, degradation potency, and any observed permeability or aggregation problems. This initial assessment defines the hydrophilic design space and identifies the most critical parameters to optimize.
Hydrophilic Linker Space Definition
Based on target structural information and project goals, we define the hydrophilic linker exploration space: PEG unit range, ionizable group candidates, amphiphilic balance targets, and environment-responsive triggers if applicable. Computational modeling of solvation, conformational ensembles, and predicted LogD7.4 helps narrow the design space to the most promising candidates before synthesis begins.
Focused Linker Library Design and Synthesis
We design and synthesize a focused series of hydrophilic linker analogs covering length gradients, polarity variations, ionizable group placement, and hybrid architectures. Each linker is prepared with appropriate protecting groups and functional handles for downstream PROTAC assembly. Clients can also leverage our linker library for rapid access to pre-designed hydrophilic building blocks.
Physicochemical and Functional Screening
Each linker analog — incorporated into the full PROTAC structure — is characterized for aqueous solubility, LogD7.4, permeability, and aggregation tendency. In parallel, we evaluate ternary complex formation, cellular degradation potency (DC50, Dmax), target selectivity, and concentration-dependent response across relevant cell models.
Structure-Property-Activity Relationship Interpretation
We correlate linker structure (PEG length, ionizable group identity, amphiphilic balance) with measured properties (solubility, LogD, permeability) and biological activity (degradation potency, selectivity, cellular response). This SPAR analysis identifies the design features that most strongly influence degrader performance and guides the selection of lead candidates.
Lead Linker Selection and Next-Round Optimization
BOC Sciences delivers a comprehensive report summarizing linker SAR, structure-property trends, degradation data, and recommended lead linkers. For programs requiring further refinement, we propose next-round design hypotheses — for example, fine-tuning PEG unit count, introducing a second ionizable group, or adjusting the amphiphilic segment ratio — to drive continued optimization.
Overcoming Large Molecular Weight Challenges
PROTACs typically range from 700 to over 1,000 Da due to their three-component architecture, which inherently limits passive diffusion and reduces aqueous solubility. Hydrophilic linkers — particularly PEG-based designs — improve water solubility and partially compensate for the penalty imposed by molecular size.
Addressing Rule-of-Five Violations
Most PROTACs violate multiple Lipinski parameters: molecular weight (>500 Da), LogP (>5), and hydrogen bond donor/acceptor counts. Hydrophilic linkers with negative LogP contributions — PEG chains or ionizable groups — directly reduce the overall LogP, helping bring the molecule closer to drug-like property space.
Reducing Nonspecific Protein Binding
Highly hydrophobic PROTACs bind nonspecifically to plasma proteins and membranes, reducing the free drug concentration available for target engagement. Hydrophilic linkers lower overall hydrophobicity, decreasing nonspecific binding and increasing the free fraction of PROTAC available to engage its intended target.
Improving Cellular Uptake and Solubility
Excessive hydrophobicity can paradoxically impair cellular permeability by promoting aggregation and precipitation rather than productive transmembrane flux. Hydrophilic linkers balance the polarity profile, reducing aggregation tendency and optimizing the physicochemical window for passive cellular uptake.

Oral PROTAC Development
Traditional PROTACs typically show very low oral bioavailability due to their large molecular weight, poor aqueous solubility, and strong plasma protein binding. Hydrophilic linkers — particularly short PEG chains or hydroxyl-containing segments — lower the overall LogP, dramatically improve water solubility, and reduce nonspecific protein binding. Key design priorities include a lower LogP, larger polar surface area, and controlled rotatable bond count.
CNS-Targeted PROTAC Design
PROTACs face formidable barriers to brain penetration: the blood-brain barrier (BBB) restricts large molecules, P-glycoprotein (P-gp) efflux pumps actively export hydrophobic compounds, and high plasma protein binding reduces the free fraction available to reach the brain. An amphiphilic balanced linker — typically PEG combined with short alkyl segments — tunes LogP into a narrow sweet spot: lipophilic enough for passive BBB diffusion, yet not so hydrophobic as to trigger P-gp recognition and export.
Tumor Microenvironment-Selective PROTACs
Conventional PROTACs distribute systemically without distinguishing tumor from normal tissue, so off-target degradation in healthy organs limits the achievable safety window. Ionizable or environment-responsive linkers take advantage of conditions unique to tumors — mildly acidic pH and elevated glutathione (GSH) levels — to achieve tumor-selective activation. pH-sensitive linkers switch hydrophilicity in the tumor microenvironment, while disulfide-PEG linkers stay stable in circulation but release active degrader once inside GSH-rich tumor cells.
Highly Hydrophobic Warhead Compensation
Certain high-value targets — including KRAS and BET family proteins — require inherently hydrophobic ligands for target engagement. These warheads impose a heavy lipophilicity burden on the overall PROTAC, driving LogP and molecular weight beyond acceptable ranges even before linker optimization. Strongly hydrophilic linkers — such as longer PEG chains, polyhydroxy scaffolds, or sulfonate-containing linkers — act as "hydrophobicity compensators," using their negative LogP contribution to offset the warhead's high lipophilicity and bring the entire degrader back into a workable property range.
Need a Hydrophilic Linker for Your PROTAC Application?
BOC Sciences supports hydrophilic PROTAC linker development across oncology, neurological, inflammatory, immune-related, and other therapeutic research programs. From linker design and custom synthesis to physicochemical evaluation, cellular testing, and iterative optimization.
PROTAC-Specific Medicinal Chemistry Expertise
Our team brings together medicinal chemists, computational modelers, and protein degradation biologists — all with years of hands-on experience designing and synthesizing PROTAC linkers across diverse target classes and E3 ligase systems. We have completed numerous custom linker design and synthesis projects, giving us a deep, practical understanding of how linker chemistry translates into real-world degrader performance.

Integrated Computational and Experimental Evaluation
We combine molecular dynamics simulation, solvation modeling, and conformational analysis with experimental solubility, LogD, permeability, ternary complex, and cellular degradation data. This tight integration between computation and experiment means we prioritize linker candidates that are both chemically feasible and biologically meaningful.
Customized Linker Libraries
For teams needing rapid access to hydrophilic building blocks, our PROTAC linker catalog offers a broad selection of ready-to-ship PEG linkers, heterobifunctional linkers, and functionalized scaffolds. Beyond off-the-shelf options, we design and synthesize fully customized hydrophilic linker libraries tuned to your specific project — spanning PEG length gradients, ionizable group placements, amphiphilic balance variations, and environment-responsive triggers for systematic SAR exploration.
Flexible Support from Linker Design to Functional Validation
Clients can engage BOC Sciences at any stage — from standalone hydrophilic linker design consultation to full design-synthesis-evaluation programs. Whether you need a single optimized PEG linker, a focused hydrophilic linker library, or a complete degrader optimization campaign with integrated ternary complex and cellular degradation readouts, our service model adapts to your project needs and decision timeline.
Project Background
A US-based biotechnology team was developing a VHL-recruiting BRD4 PROTAC using a triazolobenzodiazepine-derived BET ligand. Their lead compound used a long PEG8 linker that provided adequate solubility but suffered from weak and inconsistent cellular degradation — the excessive flexibility of the long PEG chain appeared to limit productive ternary complex formation.
Technical Challenges
The team faced a classic PROTAC dilemma: longer PEG linkers improved solubility but introduced conformational entropy that weakened ternary complex cooperativity, while simply switching to a short alkyl linker collapsed solubility entirely — requiring a systematic search for the narrow window where both properties were acceptable.
BOC Sciences Solutions
Project Outcomes
An alkyne-PEG4 hybrid linker emerged as the optimal design — the central alkyne restricted conformational freedom to strengthen ternary complex cooperativity, while flanking PEG2 segments maintained solubility above 85 μg/mL. The optimized degrader achieved a 3.5-fold improvement in DC50 with more consistent degradation and reduced hook effect compared to the original PEG8 design. The client used the comprehensive linker SAR map to select backup analogs and directly inform their next-generation BRD4 degrader series.
Project Background
A European pharmaceutical group was optimizing a covalent BTK degrader built from an acrylamide-based BTK warhead and a CRBN ligand. Hydrophobic linker variants precipitated from assay medium during in vitro testing, producing inconsistent degradation readouts that confounded SAR interpretation.
Technical Challenges
The combined POI ligand and E3 ligand system had an estimated LogP above 4 before the linker was even attached. Alkyl linkers of varying lengths all produced PROTACs that precipitated above 1 μM — making reliable DC50 determination impossible. The challenge was introducing enough hydrophilicity to prevent precipitation without creating a molecule too polar to cross cell membranes.
BOC Sciences Solutions
Project Outcomes
A PEG3-piperazine hybrid linker provided the optimal balance — sufficient hydrophilicity to achieve LogD7.4 of 2.9 and solubility above 25 μM, while the piperazine ring preserved cellular permeability. The optimized analog achieved consistent BTK degradation (DC50 = 12 nM, CV = 11%) and eliminated the precipitation artifacts that had confounded the client's SAR studies. The PEG3-piperazine architecture was adopted as a privileged linker motif across additional kinase targets in the client's portfolio.
Hydrophilic linker selection should consider the target ligand, E3 ligase ligand, attachment sites, required molecular distance, and the physicochemical behavior of the complete PROTAC. PEG chains, heteroatom-rich spacers, polar heterocycles, ionizable groups, and hydrophilic semi-rigid structures provide different levels of polarity, flexibility, and conformational control. BOC Sciences can design focused linker series with systematic variations in length, polarity, branching, and rigidity. Candidate structures can then be compared using solubility, LogD7.4, permeability, ternary complex formation, and degradation data to identify a suitable architecture.
No. Increasing linker hydrophilicity may improve aqueous behavior and reduce aggregation, but excessive PEG content, exposed polarity, or hydrogen-bonding capacity can reduce membrane permeability and intracellular exposure. A highly flexible hydrophilic linker may also introduce conformational entropy that weakens productive ternary complex formation. The objective is therefore not to maximize hydrophilicity or minimize LogP in isolation. Effective design balances solubility, permeability, molecular folding, ternary complex geometry, and degradation performance. Each target ligand and E3 ligase combination may require a different linker composition and property window.
Useful starting information includes the structures of the target protein ligand and E3 ligase ligand, available attachment positions, known binding modes, preferred linker types, existing PROTAC data, and the main development challenge. Relevant problems may include low solubility, weak cellular degradation, aggregation, limited permeability, or synthetic difficulty. Clients may also provide published reference structures or literature-based design concepts. When experimental information is limited, BOC Sciences can use ligand structures, exit-vector analysis, and intended research applications to define an initial linker space and propose a practical series for synthesis and comparative evaluation.
Hydrophilic linkers are most informative when evaluated as part of the complete PROTAC rather than as isolated fragments. BOC Sciences can compare aqueous solubility, LogD7.4, aggregation tendency, membrane permeability, target binding, ternary complex formation, DC50, Dmax, and time-dependent degradation across a focused analog series. Linking these results to PEG length, ionizable group position, linker flexibility, and conformational restriction establishes a structure-property-activity relationship. This analysis supports lead linker selection and helps define the most informative structural changes for the next optimization cycle.
Storage and shipping conditions depend on the individual structure, material form, and available stability information, so a single condition should not be applied to every linker. BOC Sciences generally supplies stock and custom products in sealed, clearly labeled packaging and selects ambient, cooled, or other appropriate shipping conditions according to product requirements. Upon receipt, clients should inspect the package and follow the conditions stated on the product label, accompanying documentation, or project instructions. Protection from moisture, light, or repeated temperature changes should be applied when specified. Handling of solutions, including freeze-thaw control, should follow product-specific guidance.
Rapid Access from Ready Stock
"We needed a set of monodisperse PEG linkers with orthogonal protecting groups for rapid PROTAC assembly. BOC Sciences had exactly what we needed in stock, and the well-characterized intermediates saved us weeks of in-house synthesis. The ability to order PEG3 through PEG8 linkers with different terminal functionalities from a single source streamlined our early SAR exploration significantly."
— Dr. Eriksen, Senior Scientist at a Japanese Oncology Biotech
Tailored Linker Design
"Our target protein ligand was extremely hydrophobic, and every PROTAC we made showed poor solubility regardless of which E3 ligase we used. BOC Sciences designed a custom hydrophilic linker strategy incorporating sulfonamide and PEG segments that brought our degrader into a workable solubility range without sacrificing degradation activity. Their understanding of how linker polarity interacts with ternary complex geometry was impressive."
— Dr. Carpenter, Medicinal Chemistry Lead at a European CRO
Precision Custom Synthesis at Scale
"We required a branched PEG linker with three orthogonal functional handles — one for the POI ligand, one for the E3 ligase ligand, and one for a fluorescent tag. BOC Sciences not only designed a feasible synthetic route but delivered multi-gram quantities of the linker with excellent purity. The synthesis team communicated proactively about protecting group strategy and coupling conditions, which made our downstream PROTAC assembly straightforward."
— Senior Scientist at a US-Based Biotechnology Company
Comprehensive Evaluation and Optimization
"What set BOC Sciences apart was the combination of synthesis and evaluation. They didn't just make the linkers we requested — they characterized solubility, LogD, permeability, and degradation for each analog and delivered a clear SPAR report. The data directly guided our decision to advance a PEG4-piperazine hybrid linker into the next optimization cycle."
— Project Lead at an Asia-Pacific Biotechnology Company
* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Please contact us with any specific requirements and we will get back to you as soon as possible.